Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% of the pediatric population associated with alteration of skin and gut microbiome. Probiotics have been proposed for AD treatment. The ProPAD study aimed to investigate the therapeutic effects of the probio...

Descripción completa

Detalles Bibliográficos
Autores principales: Carucci, Laura, Nocerino, Rita, Paparo, Lorella, De Filippis, Francesca, Coppola, Serena, Giglio, Veronica, Cozzolino, Tommaso, Valentino, Vincenzo, Sequino, Giuseppina, Bedogni, Giorgio, Russo, Roberto, Ercolini, Danilo, Berni Canani, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542056/
https://www.ncbi.nlm.nih.gov/pubmed/36003050
http://dx.doi.org/10.1111/pai.13836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542056/
https://www.ncbi.nlm.nih.gov/pubmed/36003050
http://dx.doi.org/10.1111/pai.13836

Ejemplares similares